Skip to content

Clinical trials

Breast Neoplasms trials in Portugal with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Not applicable Country / region: Portugal Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20142
20152
20162
20171
20181
20191
20211
20221
20232
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Active, not recruiting4
Unknown status2
Not yet recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundacao Champalimaud3
Associacao de Investigacao de Cuidados de Suporte em Oncologia2
ETOP IBCSG Partners Foundation2
Biosistemak Institute for Health Systems Research1
Centro Hospitalar Universitário de Santo António1
European Organisation for Research and Treatment of Cancer - EORTC1
Faculdade de Motricidade Humana1
Grupo Lusófona1
Grupo de Investigación Clínica en Oncología Radioterapia1
Heidelberg University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms23
Breast Cancer Lymphedema1
Edema1
Fatigue1
Infertility1
Lung Neoplasms1
Neoplasm Metastasis1
Neoplasms1
Pathologic Complete Response1
Sexual Dysfunction, Physiological1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.